JCR Pharmaceuticals saw the highest growth of 2.99% in patent filings in April and 3.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of JCR Pharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
JCR Pharmaceuticals has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 36% filings and 33% grants. The United States(US), World Intellectual Property Organization(WIPO), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where JCR Pharmaceuticals is filings its patents. Among the top granted patent authorities, JCR Pharmaceuticals has 33% of its grants in United States(US), 33% in Israel(IL) and 17% in European Patent Office(EPO).
Regeneron Pharmaceuticals could be the strongest competitor for JCR Pharmaceuticals
Patents related to rare diseases and cell & gene therapy lead JCR Pharmaceuticals's portfolio
JCR Pharmaceuticals has the highest number of patents in rare diseases followed by, cell & gene therapy. For rare diseases, nearly 67% of patents were filed and 100% of patents were granted in Q2 2024.
Healthcare it related patents lead JCR Pharmaceuticals portfolio followed by other remote patient monitoring, and mucopolysaccharidosis i (mps i) (hurler syndrome )
JCR Pharmaceuticals has highest number of patents in healthcare it followed by other remote patient monitoring, mucopolysaccharidosis i (mps i) (hurler syndrome ), mucopolysaccharidosis ii (mps ii) (hunter syndrome ), and pompe disease.
For comprehensive analysis of JCR Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
